| Ticker Details |
Bruker Corporation Common Stock
Bruker Corp is a developer, manufacturer and distributor of scientific instruments and analytical and dignostic solutions that enable customers to explore life and materials at microscopic, molecular and cellular levels.
|
| IPO Date: |
July 2, 2003 |
| Sector: |
Healthcare |
| Industry: |
Life Sciences Tools and Services |
| Market Cap: |
$9.07B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.48 | 1.84%
|
| Avg Daily Range (30 D): |
$1.93 | 3.25%
|
| Avg Daily Range (90 D): |
$1.71 | 3.24%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.72M |
| Avg Daily Volume (30 D): |
1.92M |
| Avg Daily Volume (90 D): |
2.06M |
| Trade Size |
| Avg Trade Size (Sh.): |
89 |
| Avg Trade Size (Sh.) (30 D): |
61 |
| Avg Trade Size (Sh.) (90 D): |
63 |
| Institutional Trades |
| Total Institutional Trades: |
10,865 |
| Avg Institutional Trade: |
$2.8M |
| Avg Institutional Trade (30 D): |
$3.69M |
| Avg Institutional Trade (90 D): |
$3.89M |
| Avg Institutional Trade Volume: |
.07M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$5.47M |
| Avg Closing Trade (30 D): |
$15.8M |
| Avg Closing Trade (90 D): |
$14.51M |
| Avg Closing Volume: |
116.15K |
|
|
| Financials |
| |
TTM |
Q2 2026 |
Q1 2026 |
|
Basic EPS
|
$-.7
|
$-.41
|
$.02
|
|
Diluted EPS
|
$-.7
|
$-.41
|
$.02
|
|
Revenue
|
$3.5B
|
$838.5M
|
$823.4M
|
|
Gross Profit
|
$1.62B
|
$416M
|
$379.8M
|
|
Net Income / Loss
|
$-64.5M
|
$-50.9M
|
$15.7M
|
|
Operating Income / Loss
|
$-30.6M
|
$-65.3M
|
$10.2M
|
|
Cost of Revenue
|
$1.88B
|
$422.5M
|
$443.6M
|
|
Net Cash Flow
|
$92.9M
|
$51.5M
|
$-165.5M
|
|
PE Ratio
|
|
|
|
|
|
|
